Skip to main content

Cell Therapy with GABAergic interneuron precursors for Early Infantil Epileptic Encephalopathies (S. Dravet, S. West y S. Stxbp1)

(Cell-based Therapy for Neuropathologies Lab)


Cell Therapy with GABAergic interneuron precursors for Early Infantil Epileptic Encephalopathies (S. Dravet, S. West y S. Stxbp1)

Read More

Cell Therapy with GABAergic interneuron precursors for Early Infantil Epileptic Encephalopathies (S. Dravet, S. West y S. Stxbp1)

(Cell-based Therapy for Neuropathologies Lab)


Cell Therapy with GABAergic interneuron precursors for Early Infantil Epileptic Encephalopathies (S. Dravet, S. West y S. Stxbp1)

Read More

Investigating Epilepsy by Super-resolution Imaging of Synapses and the Extracellular Space in Live Brain Tissue

(Laboratory of Neuronal Excitability)


 

Investigating Epilepsy by Super-resolution Imaging of Synapses and the Extracellular Space in Live Brain Tissue

Read More

Investigating Epilepsy by Super-resolution Imaging of Synapses and the Extracellular Space in Live Brain Tissue

(Laboratory of Neuronal Excitability)


 

Investigating Epilepsy by Super-resolution Imaging of Synapses and the Extracellular Space in Live Brain Tissue

Read More

Creation of a therapeutic drug monitoring (TDM) unit for the optimization of the Dravet syndrome pharmacological therapy

(Laboratory of Bioactive Research and Development (LIDeB))

 

To create a therapeutic drug monitoring (TDM) unit to carry out the analytical determination in biological fluids of the anticonvulsant drugs used in the treatment of Dravet syndrome.

Read More

Creation of a therapeutic drug monitoring (TDM) unit for the optimization of the Dravet syndrome pharmacological therapy

(Laboratory of Bioactive Research and Development (LIDeB))

 

To create a therapeutic drug monitoring (TDM) unit to carry out the analytical determination in biological fluids of the anticonvulsant drugs used in the treatment of Dravet syndrome.

Read More

Characterization of the didys552 zebrafish mutant line (mutation in snc1lab gene) and set up of an efficacy drug screening assay using reference compounds

(
Dravet unit in Biobide)

 

Characterization of the didys552 zebrafish mutant line (mutation in snc1lab gene) and set up of an efficacy drug screening assay using reference compounds.

Read More

Characterization of the didys552 zebrafish mutant line (mutation in snc1lab gene) and set up of an efficacy drug screening assay using reference compounds

(
Dravet unit in Biobide)

 

Characterization of the didys552 zebrafish mutant line (mutation in snc1lab gene) and set up of an efficacy drug screening assay using reference compounds.

Read More

(Developmental Biology and Disease Models)

The Apoyodravet Association (AD) central pillars are social innovation, patient-oriented technology and the promotion of research in the service of disease modification.

If you want to stay updated on the INDRE international research network please...